A comparative study of the effectiveness of HN2 and cyclophosphamide in bronchogenic carcinoma, Hodgkin's disease and lymphosarcoma.
D000970:Antineoplastic Agents / Q000628:therapy*; D002283:Carcinoma, Bronchogenic / Q000628:therapy*; D003520:Cyclophosphamide; D006689:Hodgkin Disease / Q000628:therapy*; D008175:Lung Neoplasms / Q000628:therapy*; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*; D008466:Mechlorethamine; D009588:Nitrogen Mustard Compounds / Q000628:therapy*
D000970:Antineoplastic Agents; D009588:Nitrogen Mustard Compounds; D008466:Mechlorethamine; D003520:Cyclophosphamide
ANTINEOPLASTIC AGENTS/therapy; CARCINOMA, BRONCHOGENIC/therapy; HODGKIN'S DISEASE/therapy; LUNG NEOPLASMS/therapy; LYMPHOSARCOMA/therapy; NITROGEN MUSTARDS/therapy